Study on 99mTc(I) Labeled Trastuzumab Monoclonal Antibody as a Specific Marker of HER2-overexpressed Cells for Breast Cancer Imaging
碩士 === 國立清華大學 === 生醫工程與環境科學系 === 94 === Herceptin, the common anti-breast cancer medicine prevailed in recent years, contains mainly trastuzumab. Trastuzumab, the DNA recombinated humanized monoclonal antibody (mAb), can recognize specifically Human Epidermal Growth Factor Receptor 2 protein (HER2)...
Main Authors: | Chao-Liang Yen, 顏肇良 |
---|---|
Other Authors: | Jem-Mau Lo |
Format: | Others |
Language: | zh-TW |
Published: |
2006
|
Online Access: | http://ndltd.ncl.edu.tw/handle/84920643406943426819 |
Similar Items
-
Radiolabeling of Herceptin with 99mTc as a Her2 tracer
by: Samira Heydari, et al.
Published: (2014-08-01) -
Biodistribution of free 99mTc-ovalbumin and 99mTc-ovalbumin encapsulated in liposomes
by: Andrea Catão Alves, et al.
Published: (2005-10-01) -
Comparison of 99mTc-DMSA, 99mTc-DTPA and 99mTc-MAG3 Renal Scintigraphy in the Calculation of Relative Renal Function
by: Fadime Demir, et al.
Published: (2020-06-01) -
99mTc Labeled Glucagon-Like Peptide-1-Analogue (99mTc-GLP1) Scintigraphy in the Management of Patients with Occult Insulinoma.
by: Anna Sowa-Staszczak, et al.
Published: (2016-01-01) -
Comparison of relative renal function measured with either 99mTc-DTPA or 99mTc-EC dynamic scintigraphies with that measured with 99mTc-DMSA static scintigraphy
by: F. C. Domingues, et al.
Published: (2006-08-01)